Search Results - "Poder, Airi"

Immunogenicity, reactogenicity and safety of 2 doses of an adjuvanted herpes zoster subunit vaccine administered 2, 6 or 12 months apart in older adults: Results of a phase III, randomized, open-label, multicenter study.

Authors: Lal, Himal Poder, Airi Campora, Laura et al.

Source: Vaccine. Jan2018, Vol. 36 Issue 1, p148-154. 7p.

An observer-blind, randomized, multi-center trial assessing long-term safety and immunogenicity of AS03-adjuvanted or unadjuvanted H1N1/2009 influenza vaccines in children 10–17 years of age.

Authors: Poder, Airi Simurka, Pavol Li, Ping et al.

Source: Vaccine. Feb2014, Vol. 32 Issue 9, p1121-1129. 9p.

Prevention of influenza during mismatched seasons in older adults with an MF59-adjuvanted quadrivalent influenza vaccine: a randomised, controlled, multicentre, phase 3 efficacy study.

Authors: Beran, Jiří Reynales, Humberto Poder, Airi et al.

Source: Lancet Infectious Diseases. Jul2021, Vol. 21 Issue 7, p1027-1037. 11p.

A Phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of V114 compared with PCV13 in healthy infants (PNEU-PED-EU-1).

Authors: Martinon-Torres, Federico Wysocki, Jacek Szenborn, Leszek et al.

Source: Vaccine. May2023, Vol. 41 Issue 21, p3387-3398. 12p.

Corrigendum to 'Immunogenicity and safety of the adjuvanted recombinant zoster vaccine co-administered with the 23-valent pneumococcal polysaccharide vaccine in adults ≥50 years of age: A randomized trial' [Vaccine 36 (2018) 4278–4286].

Authors: Maréchal, Céline Lal, Himal Poder, Airi et al.

Source: Vaccine. Feb2019, Vol. 37 Issue 9, p1252-1253. 2p.

Corrigendum to "A Phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of V114 compared with PCV13 in healthy infants (PNEU-PED-EU-1)" [Vaccine 41 (2023) 3387–3398]

Authors: Martinon-Torres, Federico Wysocki, Jacek Szenborn, Leszek et al.

Source: Vaccine. Feb2025, Vol. 48, pN.PAG-N.PAG. 1p.

Immunogenicity and safety of the adjuvanted recombinant zoster vaccine co-administered with the 23-valent pneumococcal polysaccharide vaccine in adults ≥50 years of age: A randomized trial.

Authors: Maréchal, Céline Lal, Himal Heineman, Thomas C et al.

Source: Vaccine. Jul2018, Vol. 36 Issue 29, p4278-4286. 9p.

Efficacy and safety of the ustekinumab biosimilar, Bmab 1200, versus reference ustekinumab in moderate-to-severe plaque psoriasis: 28‑week results of the randomized, double-blind, Phase 3 STELLAR-2 study.

Authors: Szepietowski JC Reich A Feldman SR et al.

Source: Expert opinion on biological therapy [Expert Opin Biol Ther] 2025 Aug; Vol. 25 (8), pp. 913-924. Date of Electronic Publication: 2025 Jul 29.

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study; Comparative Study

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101125414 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7682 (Electronic) Linking ISSN: 14712598 NLM ISO Abbreviation: Expert Opin Biol Ther Subsets: MEDLINE

Comparative efficacy and safety of biosimilar Bmab 1200 versus reference ustekinumab in moderate-to-severe plaque psoriasis: 52-week findings from the Phase 3 STELLAR-2 trial.

Authors: Szepietowski JC Reich A Feldman SR et al.

Source: Expert opinion on biological therapy [Expert Opin Biol Ther] 2025 Oct; Vol. 25 (10), pp. 1121-1133. Date of Electronic Publication: 2025 Oct 21.

Publication Type: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Comparative Study; Multicenter Study

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101125414 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7682 (Electronic) Linking ISSN: 14712598 NLM ISO Abbreviation: Expert Opin Biol Ther Subsets: MEDLINE

Immunogenicity and Safety of MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared with a Nonadjuvanted, Quadrivalent Influenza Vaccine in Adults 50-64 Years of Age.

Authors: Poder A Oberije J Meyer J et al.

Source: Vaccines [Vaccines (Basel)] 2023 Sep 26; Vol. 11 (10). Date of Electronic Publication: 2023 Sep 26.

Publication Type: Journal Article

Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101629355 Publication Model: Electronic Cited Medium: Print ISSN: 2076-393X (Print) Linking ISSN: 2076393X NLM ISO Abbreviation: Vaccines (Basel) Subsets: PubMed not MEDLINE

Immunological non-inferiority of a new fully liquid presentation of the MenACWY-CRM vaccine to the licensed vaccine: results from a randomized, controlled, observer-blind study in adolescents and young adults.

Authors: Díez-Domingo J Tinoco JC Poder A et al.

Source: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Dec 31; Vol. 18 (1), pp. 1981085. Date of Electronic Publication: 2021 Oct 06.

Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Equivalence Trial

Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE

A Phase III, Randomized, Controlled Trial of Apremilast in Patients with Psoriatic Arthritis: Results of the PALACE 2 Trial.

Authors: Cutolo M Myerson GE Fleischmann RM et al.

Source: The Journal of rheumatology [J Rheumatol] 2016 Sep; Vol. 43 (9), pp. 1724-34. Date of Electronic Publication: 2016 Jul 15.

Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Journal Of Rheumatology Publishing Co Country of Publication: Canada NLM ID: 7501984 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1499-2752 (Electronic) Linking ISSN: 0315162X NLM ISO Abbreviation: J Rheumatol Subsets: MEDLINE

Evaluation of ID-PaGIA syphilis antibody test.

Authors: Naaber P Makoid E Aus A et al.

Source: Indian journal of dermatology, venereology and leprology [Indian J Dermatol Venereol Leprol] 2009 Sep-Oct; Vol. 75 (5), pp. 492-4.

Publication Type: Comparative Study; Evaluation Study; Journal Article

Journal Info: Publisher: Scientific Scholar on behalf of Indian Association of Dermatologists, Venereologists & Leprologists Country of Publication: United States NLM ID: 7701852 Publication Model: Print Cited Medium: Internet ISSN: 0973-3922 (Electronic) Linking ISSN: 03786323 NLM ISO Abbreviation: Indian J Dermatol Venereol Leprol Subsets: MEDLINE

The growing and important collaboration between BASHH and IUSTI-Europe.

Authors: Patel R Sherrard J Richardson D et al.

Source: Sexually transmitted infections [Sex Transm Infect] 2018 Nov; Vol. 94 (7), pp. 474. Date of Electronic Publication: 2018 Jul 17.

Publication Type: Journal Article

Journal Info: Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 9805554 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1472-3263 (Electronic) Linking ISSN: 13684973 NLM ISO Abbreviation: Sex Transm Infect Subsets: MEDLINE

Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults.

Authors: Lal H Cunningham AL Godeaux O et al.

Corporate Authors: Lal H Cunningham AL Godeaux O et al.

Source: The New England journal of medicine [N Engl J Med] 2015 May 28; Vol. 372 (22), pp. 2087-96. Date of Electronic Publication: 2015 Apr 28.

Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

Long-term persistence of systemic and mucosal immune response to HPV-16/18 AS04-adjuvanted vaccine in preteen/adolescent girls and young women.

Authors: Petäjä T Pedersen C Poder A et al.

Source: International journal of cancer [Int J Cancer] 2011 Nov 01; Vol. 129 (9), pp. 2147-57. Date of Electronic Publication: 2011 Mar 11.

Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE

Immunization of early adolescent females with human papillomavirus type 16 and 18 L1 virus-like particle vaccine containing AS04 adjuvant.

Authors: Pedersen C Petaja T Strauss G et al.

Corporate Authors: Pedersen C Petaja T Strauss G et al.

Source: The Journal of adolescent health : official publication of the Society for Adolescent Medicine [J Adolesc Health] 2007 Jun; Vol. 40 (6), pp. 564-71.

Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 9102136 Publication Model: Print Cited Medium: Internet ISSN: 1879-1972 (Electronic) Linking ISSN: 1054139X NLM ISO Abbreviation: J Adolesc Health Subsets: MEDLINE